EVENT: Hydrotherapy and Deep Venous Thrombosis

NCT ID: NCT00348907

Last Updated: 2007-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

3 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-07-31

Study Completion Date

2006-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to demonstrate that hydrotherapy in a specific place can reduce the risk of post-thrombotic syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Venous thrombo-embolic disease (VTED) is a frequent pathology. The incidence is about 5 to 20 cases for 10000 persons each year, in a general population. The immediate risk is the pulmonary embolism potentially fatal. So, it justifies all the works in clinical research during the last years. Those studies allow many progresses, diagnostic and therapeutic, for the immediate undertaking of the patients. Despite that, VTED is a major problem of public health and the diminution of the mortality lied to VTED is one of the objectives of the French law relative to the politics of Public Health (August 2004). At more long-term, the post-thrombotic syndrome lead to an incapacitating pathology, which requires many cares. The frequency of the post-thrombotic syndrome is evaluated between 25 and 60% at middle-term (1 or 2 years). It depends of the studies and of the clinical primary end-points or vascular explorations. Rehabilitation has never been validated in this indication by studies with a correct methodology.

Deep venous thrombosis (not in acute phase) is recognized as an indication for about 10 spa in France. But the specific or global benefit of this water cure is not clearly and scientifically proved. The importance of the venous pump of the calf and of the hydrostatic pressure in the physiopathology of the post-thrombotic syndrome make natural the use of balneotherapy for the prevention of this pathology for patients with severe deep venous thrombosis of lower limbs (proximal and obstruent). The venous thermal techniques have well-defined physiopathological targets. The haemodynamic and microcirculatory effects of some of them have been proved. The high degree of satisfaction of the patients that benefit from phlebological water cure every year in France indirectly shows the benefits that they feel. In those indications, prevention of the post-thrombotic syndrome is one of the well-recognize by the medical profession. For all that, there was not really validation of this indication with an acceptable methodology for the canons of the modern medicine. That is the reason why we undertake this randomized, single-blind controlled study with for main objective to demonstrate that hydrotherapy in a specific place can reduce the risk of post-thrombotic syndrome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Deep Venous Thrombosis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

doppler CIVIQ quality of life Hydrotherapy anticoagulants

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

immediate thermal cure (1st year)

Group Type ACTIVE_COMPARATOR

thermal cure

Intervention Type DRUG

thermal cure of 18 days including movement in swimming pool, mud-bath, shower, massage and thermal steam

2

late thermal cure (2 years)

Group Type SHAM_COMPARATOR

late thermal cure

Intervention Type DRUG

thermal cure of 18 days including movement in swimming pool, mud-bath, shower, massage and thermal steam at 2 years

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

thermal cure

thermal cure of 18 days including movement in swimming pool, mud-bath, shower, massage and thermal steam

Intervention Type DRUG

late thermal cure

thermal cure of 18 days including movement in swimming pool, mud-bath, shower, massage and thermal steam at 2 years

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* both sexes;
* 18 years old and more;
* clinical indication of thermal cure (first phase of deep venous thrombosis authenticated by unilateral venous echo-doppler
* curative anticoagulant treatment more than 3 month;
* oedema and/or spontaneous pain with functional discomfort;
* available for a thermal cure during 18 days and a follow-up period of 36 month;
* voluntary to participate to the study, informed consent form signed after appropriate information;
* affiliation to the social security system or equivalent;
* no previous participation to a thermal cure (in the indication of phlebology)

Exclusion Criteria

* isolate distal thrombosis;
* asymptomatic thrombosis;
* cutaneous ulcer of lower limb;
* refusal to consent;
* refusal to benefit of thermal cure;
* contra-indication to hydrotherapy.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Association Francaise pour la Recherche Thermale

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

François POIRAULT, Dr

Role: PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Etablissement thermal

Argelès-Gazost, , France

Site Status

Etablissement thermal

Bagnoles-de-l'Orne, , France

Site Status

Etablissement thermal

Barbotan-les-Thermes, , France

Site Status

L'avenue

Dax, , France

Site Status

Sarrailh

Dax, , France

Site Status

Le Splendid

Dax, , France

Site Status

Les thermes

Dax, , France

Site Status

Le miradour

Dax, , France

Site Status

Les arènes

Dax, , France

Site Status

Bérot

Dax, , France

Site Status

Les écureuils

Dax, , France

Site Status

Dax thermal

Dax, , France

Site Status

Foch

Dax, , France

Site Status

Borda

Dax, , France

Site Status

Saint-Pierre

Dax, , France

Site Status

Le Grand Hôtel

Dax, , France

Site Status

Le Regina

Dax, , France

Site Status

Etablissement thermal

Évian-les-Bains, , France

Site Status

Domaine d'heurteboise

Jonzac, , France

Site Status

Etablissement thermal

La Léchère, , France

Site Status

Etablissement thermal

Luxeuil-les-Bains, , France

Site Status

Etablissement thermal

Luz-Saint-Sauveur, , France

Site Status

Etablissement thermal

Rochefort, , France

Site Status

Caliceo

Saint-Paul-lès-Dax, , France

Site Status

Christus

Saint-Paul-lès-Dax, , France

Site Status

Chênes

Saint-Paul-lès-Dax, , France

Site Status

Etablissmeent thermal

Saubusse-les-bains, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996 Jul 1;125(1):1-7. doi: 10.7326/0003-4819-125-1-199607010-00001.

Reference Type BACKGROUND
PMID: 8644983 (View on PubMed)

Kahn SR, Kearon C, Julian JA, Mackinnon B, Kovacs MJ, Wells P, Crowther MA, Anderson DR, Van Nguyen P, Demers C, Solymoss S, Kassis J, Geerts W, Rodger M, Hambleton J, Ginsberg JS; Extended Low-intensity Anticoagulation for Thrombo-embolism (ELATE) Investigators. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost. 2005 Apr;3(4):718-23. doi: 10.1111/j.1538-7836.2005.01216.x. Epub 2005 Feb 23.

Reference Type BACKGROUND
PMID: 15733061 (View on PubMed)

Labropoulos N, Leon LR Jr. Duplex evaluation of venous insufficiency. Semin Vasc Surg. 2005 Mar;18(1):5-9. doi: 10.1053/j.semvascsurg.2004.12.002.

Reference Type BACKGROUND
PMID: 15791546 (View on PubMed)

Asbeutah AM, Riha AZ, Cameron JD, McGrath BP. Reproducibility of duplex ultrasonography and air plethysmography used for the evaluation of chronic venous insufficiency. J Ultrasound Med. 2005 Apr;24(4):475-82. doi: 10.7863/jum.2005.24.4.475.

Reference Type BACKGROUND
PMID: 15784766 (View on PubMed)

Launois R, Reboul-Marty J, Henry B. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Qual Life Res. 1996 Dec;5(6):539-54. doi: 10.1007/BF00439228.

Reference Type BACKGROUND
PMID: 8993100 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DCIC 05 45

Identifier Type: -

Identifier Source: org_study_id